124750-51-2 99%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2024-01-20
Product Details
- Product Name5-[4'-(Bromomethyl)[1,1'-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole
- CAS No.124750-51-2
- EINECS No.603-010-9
- MFC33H25BrN4
- MW557.48
- Appearance SolidWhite
- Melting point 152-155°C
- storage temp. Inert atmosphere,2-8°C
- Boiling point 61°C/12mmHg(lit.)
- density 1.28±0.1 g/cm3(Predicted)
Company Profile Introduction
Angels Pharma India Pvt. Ltd. - Manufacturer of pharmaceutical tablets, pharmaceutical syrup & other products in Visakhapatnam, Andhra Pradesh.
Angels Pharma India Private Limited is a pharmaceutical company dedicated to the development and commercialization of innovative drugs for the treatment of cancer and autoimmune diseases. With a mission to make the world's leading innovative medicines accessible to patients in need, the company has established itself as a significant player in the pharmaceutical industry, particularly in India and China.
Angels Pharma India Private Limited has established research and development centers in China's Zhejiang Jiaxing and the United States' California, Berkeley. The company has also formed a strategic partnership with Corvus Pharmaceuticals (CRVS) in the United States, which has bolstered its R&D capabilities and global reach.
The company is committed to maintaining high standards of quality and compliance across its operations. Angels Pharma India Private Limited adheres to international quality control measures and is dedicated to continuous improvement in all aspects of its operations, ensuring that its products meet the rigorous demands of the global pharmaceutical market.
With a robust pipeline of innovative drugs and a strong focus on research and development, Angels Pharma India Private Limited is well-positioned to make a significant impact in the treatment of serious diseases such as cancer and autoimmune disorders. The company's commitment to innovation, quality, and global collaboration is expected to drive its growth and expansion in the coming years, as it continues to bring cutting-edge medicines to patients worldwide.
Recommended supplier
-
VIP1年
- OXYGENTA PHARMACEUTICAL LIMITED
- N-(Triphenylmethyl)-5-(4'bromomethyl-biphenyl-2-yl)tetrazole (TTBB) 124750-51-2 99%
- Inquiry
- 2024-10-24
-
VIP1年
- Navone Specialties (OPC) Pvt Ltd
- N-(Triphenylmethyl)-5-(4'bromomethyl-biphenyl-2-yl)tetrazole (TTBB) 99%
- Inquiry
- 2024-05-02
-
VIP1年
- Sibram Pharmaceutical
- 124750-51-2 5-[4'-(Bromomethyl)[1,1'-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole 99%
- Inquiry
- 2024-03-16
-
VIP1年
- Mekong pharmaceuticals pvt ltd
- 124750-51-2 98%
- Inquiry
- 2024-03-02
-
VIP1年
- Vishrudh laboratories pvt ltd
- 124750-51-2 5-[4'-(Bromomethyl)[1,1'-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole 98%
- Inquiry
- 2024-03-01
-
VIP1年
- Maithili Life Sciences Pvt Ltd
- 5-[4'-(Bromomethyl)[1,1'-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole 124750-51-2 98%
- Inquiry
- 2024-02-23
-
VIP1年
- Ralington Pharma
- 5-[4'-(Bromomethyl)[1,1'-biphenyl]-2-yl]-1-(triphenylmethyl)-1H-tetrazole 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Raising Sun Pharma
- 124750-51-2 98%
- Inquiry
- 2024-02-03
- Since:2020-01-01
- Address: 1st floor, Shree Nilayam, Arunodaya Colony, Madhapur, hyderabad, Telangana-500081, India.